We believe that advocacy is the key to defining the future of otolaryngology. Medicare regulatory advocacy is a top priority of the AAO-HNS.
The AAO-HNS has a long history of working closely with the U.S. Department of Health and Human Services, the Centers for Medicare & Medicaid Services (CMS), and the CMS Innovation Center to maintain our visibility and credibility with national representatives regarding Medicare issues.
Hypoglossal Nerve Stimulation & Medicare’s WISeR Model FAQs
On January 1, 2026, the Center for Medicare & Medicaid Innovation (CMMI) is launching the Wasteful and Inappropriate Service Reduction (“WISeR”) Model, which will add AI-powered prior authorization for certain services in Original Medicare—including hypoglossal nerve stimulation (HGNS) for obstructive sleep apnea (OSA)—in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. The Academy has prepared a detailed list of frequently asked questions for its members in preparation.
